Anders Bylock
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Anders Bylock
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
13
| Public Company | Pharmaceuticals: Major | 13 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
4
| Public Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anders Bylock
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Endoceutics, Inc.
 Endoceutics, Inc. Pharmaceuticals: MajorHealth Technology EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BETTERLIFE PHARMA INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Director/Board Member Doctorate Degree | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
| Pace University | College/University | Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree | |
| Ruhr-Universität Bochum | College/University | Undergraduate Degree | |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO | |
| Universität Ulm | College/University | Doctorate Degree | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Aptus Health, Inc.
 Aptus Health, Inc. Miscellaneous Commercial ServicesCommercial Services Aptus Health, Inc. operates a marketing platform for physicians and health care professionals. Its services include Geo-targeting mobile advertising; clinical alerts and eNewsletters; insight and attitudinal surveys; KOL-led presentations; eDetails; Peer-to-Peer collaboration; eSampling; Electronic Health Record integration; patient feedback; segmentation and tartgeting; behavioral insights; and intelligence and reporting. The company was founded by Donato J. Tramuto in 2008 and is headquartered in Reading, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Chairman | |
Boehringer Ingelheim AB
 Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Läkemedelsindustriföreningens Service AB | Director/Board Member | ||
Boehringer Ingelheim RCV GmbH & Co. KG
 Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Founder General Counsel | |
AEterna Zentaris GmbH
 AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Boehringer Ingelheim International GmbH
 Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| Norpharma A/S | Chief Executive Officer | ||
| Mundipharma AS | Chief Executive Officer | ||
| Mundipharma Oy | Chief Executive Officer | ||
| University of Nipissing | College/University | Undergraduate Degree | |
| University of Linnaeus | College/University | Undergraduate Degree | |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Investment Managers | Chief Executive Officer | |
| Skatteverket | Comptroller/Controller/Auditor | ||
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
The Delta Projects AB
 The Delta Projects AB Advertising/Marketing ServicesCommercial Services Part of Principion Holding BV, The Delta Projects AB is a private company that provides advertising services. The company is based in Stockholm, Sweden. The Delta Projects was acquired by Principion Holding BV on July 01, 2021. The CEO of the Swedish company is John Marcus Boson Lilja. | Advertising/Marketing Services | Director/Board Member | |
| EMOTRA AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
| TERRANET AB | Information Technology Services | Director/Board Member | |
| ICON Clinical Research (Canada), Inc. | Corporate Officer/Principal Corporate Officer/Principal | ||
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| Alterhealth, Inc. | Corporate Officer/Principal | ||
| Ullman Medical, Inc. | Chief Executive Officer | ||
| Interlife Sciences, Inc. | Founder | ||
Maida Vale Capital AB
 Maida Vale Capital AB Investment Banks/BrokersFinance Maida Vale Capital AB is a private company based in Saltsjo-Boo, Sweden. The CEO of the Swedish company is Oliver Aleksov. | Investment Banks/Brokers | Director/Board Member Chairman | |
| Wonderboo AB | Director/Board Member | ||
| Challengehop, Inc. | Director/Board Member | ||
| Hunterhex International Ltd. | Director/Board Member | ||
| Hunterhex AB | Director/Board Member Director/Board Member | ||
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Schweden | 23 |
| Vereinigte Staaten | 12 |
| Deutschland | 7 |
| Kanada | 6 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 2 |
Operativ
| Director/Board Member | 91 |
| Corporate Officer/Principal | 64 |
| Chief Executive Officer | 40 |
| Chairman | 32 |
| Independent Dir/Board Member | 23 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Simone Menne | 24 |
| Karl Blom | 22 |
| Patrick Charles Frankham | 20 |
| J. Carroll | 17 |
| Wolfgang Renz | 17 |
| Lena Birgitta Degling Wikingsson | 16 |
| Kjell Göran Stenberg | 14 |
| Ulf Björklund | 14 |
| Per-Göran Gillberg | 11 |
| Hubertus von Baumbach | 11 |
| Per Wester | 10 |
| Julian Aleksov | 10 |
| Wolfgang Baiker | 10 |
| Ingela Hallberg | 9 |
| Margareth Jorvid | 9 |
- Börse
- Insiders
- Anders Bylock
- Unternehmensverbindungen
